Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith S Kaye

Showing results (391-400 of 421) with videos related to

Pageof 43
Sort By:
Scientific Reports|July 29, 2025
A network analysis of carbapenem-resistant Klebsiella pneumoniae among healthcare facilitiesCourtney L Luterbach, Dana K Pasquale, Heather I Henderson, et al.
American Journal of Infection Control|January 31, 2012
The burden of multidrug-resistant organisms on tertiary hospitals posed by patients with recent stays in long-term acute care facilitiesDror Marchaim, Teena Chopra, Christopher Bogan, et al.
Microbiology Spectrum|May 23, 2023
Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumanniiHadas Kon, Amichay Hameir, Amir Nutman, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2012
Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremiaKayoko Hayakawa, Dror Marchaim, Emily T Martin, et al.
Infectious Diseases and Therapy|October 2, 2018
Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical TrialRichard G Wunderink, Evangelos J Giamarellos-Bourboulis, Galia Rahav, et al.
Infection Control and Hospital Epidemiology|April 9, 2014
Introduction to "A Compendium of Strategies To Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 updates"Deborah S Yokoe, Deverick J Anderson, Sean M Berenholtz, et al.
Infection Control and Hospital Epidemiology|September 30, 2014
Introduction to "A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates"Deborah S Yokoe, Deverick J Anderson, Sean M Berenholtz, et al.
Infection Control and Hospital Epidemiology|October 9, 2008
Strategies to prevent clostridium difficile infections in acute care hospitalsErik R Dubberke, Dale N Gerding, David Classen, et al.
Infectious Diseases and Therapy|March 28, 2019
Open-Label Randomized Trial of Early Clinical Outcomes of Ceftaroline Fosamil Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections at Risk of Methicillin-Resistant Staphylococcus aureusKimberly C Claeys, Evan J Zasowski, Trang D Trinh, et al.
Infection Control and Hospital Epidemiology|October 9, 2008
Strategies to prevent ventilator-associated pneumonia in acute care hospitalsSusan E Coffin, Michael Klompas, David Classen, et al.
Pageof 43

Showing results (391-400 of 421) with videos related to

Sort By:
Pageof 43
Scientific Reports|July 29, 2025
A network analysis of carbapenem-resistant Klebsiella pneumoniae among healthcare facilitiesCourtney L Luterbach, Dana K Pasquale, Heather I Henderson, et al.
American Journal of Infection Control|January 31, 2012
The burden of multidrug-resistant organisms on tertiary hospitals posed by patients with recent stays in long-term acute care facilitiesDror Marchaim, Teena Chopra, Christopher Bogan, et al.
Microbiology Spectrum|May 23, 2023
Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumanniiHadas Kon, Amichay Hameir, Amir Nutman, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2012
Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremiaKayoko Hayakawa, Dror Marchaim, Emily T Martin, et al.
Infectious Diseases and Therapy|October 2, 2018
Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical TrialRichard G Wunderink, Evangelos J Giamarellos-Bourboulis, Galia Rahav, et al.
Infection Control and Hospital Epidemiology|April 9, 2014
Introduction to "A Compendium of Strategies To Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 updates"Deborah S Yokoe, Deverick J Anderson, Sean M Berenholtz, et al.
Infection Control and Hospital Epidemiology|September 30, 2014
Introduction to "A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates"Deborah S Yokoe, Deverick J Anderson, Sean M Berenholtz, et al.
Infection Control and Hospital Epidemiology|October 9, 2008
Strategies to prevent clostridium difficile infections in acute care hospitalsErik R Dubberke, Dale N Gerding, David Classen, et al.
Infectious Diseases and Therapy|March 28, 2019
Open-Label Randomized Trial of Early Clinical Outcomes of Ceftaroline Fosamil Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections at Risk of Methicillin-Resistant Staphylococcus aureusKimberly C Claeys, Evan J Zasowski, Trang D Trinh, et al.
Infection Control and Hospital Epidemiology|October 9, 2008
Strategies to prevent ventilator-associated pneumonia in acute care hospitalsSusan E Coffin, Michael Klompas, David Classen, et al.
Pageof 43